טוען...
Efficacy and steroid-sparing effect of benralizumab: has it an advantage over its competitors?
Severe refractory asthma is characterized by a higher risk of asthma-related symptoms, morbidities, and exacerbations. This disease also determines much greater healthcare costs and deterioration in health-related quality of life (HR-QoL). Another concern, which is currently much discussed, is the h...
שמור ב:
| הוצא לאור ב: | Drugs Context |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BioExcel Publishing Ltd
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6469746/ https://ncbi.nlm.nih.gov/pubmed/31024635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212580 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|